 | Related Articles |
FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?
Eur J Cancer. 2017 03;73:71-73
Authors: Modest DP, Neumann UP, Pratschke J
PMID: 28081915 [PubMed - indexed for MEDLINE]
http://ift.tt/2DNnWPC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου